The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Oroxine 75 microgram tablets

Aspen Pharma Trading LimitedPA1691/013/003

Main Information

Trade NameOroxine 75 microgram tablets
Active SubstancesLevothyroxine
Dosage FormTablet
Licence HolderAspen Pharma Trading Limited
Licence NumberPA1691/013/003

Group Information

ATC CodeH03AA Thyroid hormones
H03AA01 levothyroxine sodium


License statusAuthorised
Licence Issued12/09/2014
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back